While acknowledging that this was a relatively small retrospective study ( n = 81), the results suggest that in the future, pending further evidence, acetyl-l-carnitine might be considered as an addition to first-line treatments currently recommended by IASP
Risk Groups and Risk Factors Individuals with the diseases already described, primarily involving tumors of the liver, may develop hypercobalaminemia
Meglutide participates in the activity of the appetite regulation center
DuarteFNDRodriguesJBDa Costa LimaMLimaMDSPachecoMTBPintadoMMEet al
Asimismo, en el paciente con alto riesgo cardiovascular sera conveniente considerar escenarios de terapia puente, en combinacin o ambas, teniendo en cuenta que el efecto en la mortalidad con empagliflozina fue a los 6 meses de iniciado el tratamiento (efectos ms hemodinmicos) y con liraglutida fue a los 12 meses de iniciado el tratamiento (efecto ms vascular).
Think of these as frameworksstarting points for designing your own rigorous experiments